Parabilis Medicines, Inc.
PBLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657677
No open-market purchases or sales by Parabilis Medicines, Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $2.71B in total; no superinvestor holds it.
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:52 PM ET
No financial statements
Parabilis Medicines, Inc. has no annual statements on file yet. See the quarterly statements.